Clinical Trials Browser

Phase 2 × merestinib × Clear all

NCT02711553 2025-08-03

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

Phase 2 Active not recruiting

309 enrolled 22 charts

Gastrointestinal

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT02920996 2024-04-11

Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Phase 2 Terminated

12 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung